Latest Articles

Publication Date
Hepatic Endometriosis Misdiagnosed as Hepatic Epithelioid Hemangioendothelioma.

We describe the case of a young 42-year-old female who suffered from cyclical right upper quadrant abdominal pain that led to an emergency department visit where an intrahepatic mass was …

Published: Aug. 15, 2025, midnight
New therapeutic targets for endometriosis predicted through mendelian randomization analysis and case-control trials.

Endometriosis is a common chronic gynecological condition that affects approximately 10% of women of reproductive age worldwide.

Published: Aug. 15, 2025, midnight
Unveiling the vital role of OGG1 in inflammation, vascular endothelial damage, and cell death in obstetric and gynecological diseases.

The DNA repair enzyme 8-oxoguanine DNA glycosylase-1 (OGG1) plays a crucial role in the initiation of DNA base excision repair pathway by recognizing and excising the oxidative base lesions including …

Published: Aug. 14, 2025, midnight
Different ultrasound morphologies of rectosigmoid endometriosis nodules: an exploratory analysis of their prevalence and associated clinical characteristics.

To investigate the prevalence of various ultrasound morphologies of rectosigmoid endometriosis (RSE) nodules according to the International Deep Endometriosis Analysis (IDEA) consensus, and their potential association with distinct clinical phenotypes …

Published: Aug. 14, 2025, midnight
Single-Cell Profiling Reveals Altered Endometrial Cellular Features Across the Menstrual Cycle in Endometriosis Patients.

Endometriosis is a chronic, estrogen-dependent condition affecting over 190 million women globally, characterized by the ectopic presence of endometrial-like tissue that leads to inflammation, pain, and infertility. Despite its prevalence, …

Published: Aug. 14, 2025, midnight
Global, regional, and national burdens of endometriosis from 1990 to 2021: a trend analysis.

Endometriosis is a common, chronic, estrogen-dependent gynecological disorder that significantly affects patients' quality of life. However, the disease burden and its trends may be undergoing significant changes, and comprehensive data …

Published: Aug. 14, 2025, midnight
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times

Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire

Published: Aug. 13, 2025, 8:17 p.m.
GnRH Receptor Antagonists Market Poised for Significant - openPR.com

GnRH Receptor Antagonists Market Poised for Significant openPR.com

Published: Aug. 13, 2025, 7:52 p.m.
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis - Nature

Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis Nature

Published: Aug. 13, 2025, 2:22 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!